351 related articles for article (PubMed ID: 19535407)
21. Validity of the EQ-5D as a generic health outcome instrument in a heroin-dependent population.
van der Zanden BP; Dijkgraaf MG; Blanken P; de Borgie CA; van Ree JM; van den Brink W
Drug Alcohol Depend; 2006 Apr; 82(2):111-8. PubMed ID: 16168573
[TBL] [Abstract][Full Text] [Related]
22. A comparison of the EQ-5D-3L and ICECAP-O in an older post-acute patient population relative to the general population.
Couzner L; Crotty M; Norman R; Ratcliffe J
Appl Health Econ Health Policy; 2013 Aug; 11(4):415-25. PubMed ID: 23807538
[TBL] [Abstract][Full Text] [Related]
23. Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions.
Langelaan M; de Boer MR; van Nispen RM; Wouters B; Moll AC; van Rens GH
Ophthalmic Epidemiol; 2007; 14(3):119-26. PubMed ID: 17613846
[TBL] [Abstract][Full Text] [Related]
24. Estimating EuroQol EQ-5D scores from Population Healthy Days data.
Jia H; Lubetkin EI
Med Decis Making; 2008; 28(4):491-9. PubMed ID: 18556640
[TBL] [Abstract][Full Text] [Related]
25. [EuroQol-5D FOR quality of life assessment in cardiac rehabilitation].
Balestroni G; Omarini G; Omarini P; Zotti AM
G Ital Med Lav Ergon; 2007; 29(3 Suppl B):B56-62. PubMed ID: 18575359
[TBL] [Abstract][Full Text] [Related]
26. [The burden of depressive disorders in Germany - results from the European Study of the Epidemiology of Mental Disorders (ESEMeD)].
Günther OH; Friemel S; Bernert S; Matschinger H; Angermeyer MC; König HH
Psychiatr Prax; 2007 Sep; 34(6):292-301. PubMed ID: 17806016
[TBL] [Abstract][Full Text] [Related]
27. [Discriminative ability, construct validity and sensitivity to change of the EQ-5D quality of life questionnaire in paranoid schizophrenia].
Konnopka A; Günther OH; Angermeyer MC; König HH
Psychiatr Prax; 2006 Oct; 33(7):330-6. PubMed ID: 17024582
[TBL] [Abstract][Full Text] [Related]
28. Using the EQ-5D index score as a predictor of outcomes in patients with type 2 diabetes.
Clarke PM; Hayes AJ; Glasziou PG; Scott R; Simes J; Keech AC
Med Care; 2009 Jan; 47(1):61-8. PubMed ID: 19106732
[TBL] [Abstract][Full Text] [Related]
29. Responsiveness of EQ-5D utility indices in alcohol-dependent patients.
Günther OH; Roick C; Angermeyer MC; König HH
Drug Alcohol Depend; 2008 Jan; 92(1-3):291-5. PubMed ID: 17888587
[TBL] [Abstract][Full Text] [Related]
30. The transformation of utilities for health states worse than death: consequences for the estimation of EQ-5D value sets.
Lamers LM
Med Care; 2007 Mar; 45(3):238-44. PubMed ID: 17304081
[TBL] [Abstract][Full Text] [Related]
31. Estimation of the impact of genital warts on health-related quality of life.
Woodhall S; Ramsey T; Cai C; Crouch S; Jit M; Birks Y; Edmunds WJ; Newton R; Lacey CJ
Sex Transm Infect; 2008 Jun; 84(3):161-6. PubMed ID: 18339658
[TBL] [Abstract][Full Text] [Related]
32. Distribution and determinants of health and work status in a comprehensive population of injury patients.
Meerding WJ; Looman CW; Essink-Bot ML; Toet H; Mulder S; van Beeck EF
J Trauma; 2004 Jan; 56(1):150-61. PubMed ID: 14749582
[TBL] [Abstract][Full Text] [Related]
33. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus.
Aggarwal R; Wilke CT; Pickard AS; Vats V; Mikolaitis R; Fogg L; Block JA; Jolly M
J Rheumatol; 2009 Jun; 36(6):1209-16. PubMed ID: 19369452
[TBL] [Abstract][Full Text] [Related]
34. Validation of the EQ-5D questionnaire in burn injured adults.
Oster C; Willebrand M; Dyster-Aas J; Kildal M; Ekselius L
Burns; 2009 Aug; 35(5):723-32. PubMed ID: 19297100
[TBL] [Abstract][Full Text] [Related]
35. EQ-5D-5L norms for the urban Chinese population in China.
Yang Z; Busschbach J; Liu G; Luo N
Health Qual Life Outcomes; 2018 Nov; 16(1):210. PubMed ID: 30409137
[TBL] [Abstract][Full Text] [Related]
36. Quality-of-life weights for the US population: self-reported health status and priority health conditions, by demographic characteristics.
Nyman JA; Barleen NA; Dowd BE; Russell DW; Coons SJ; Sullivan PW
Med Care; 2007 Jul; 45(7):618-28. PubMed ID: 17571010
[TBL] [Abstract][Full Text] [Related]
37. A single European currency for EQ-5D health states. Results from a six-country study.
Greiner W; Weijnen T; Nieuwenhuizen M; Oppe S; Badia X; Busschbach J; Buxton M; Dolan P; Kind P; Krabbe P; Ohinmaa A; Parkin D; Roset M; Sintonen H; Tsuchiya A; de Charro F
Eur J Health Econ; 2003 Sep; 4(3):222-31. PubMed ID: 15609189
[TBL] [Abstract][Full Text] [Related]
38. Estimating EQ-5D utility values for major health behavioural risk factors in England.
Maheswaran H; Petrou S; Rees K; Stranges S
J Epidemiol Community Health; 2013 Feb; 67(2):172-80. PubMed ID: 22844084
[TBL] [Abstract][Full Text] [Related]
39. Outcome after injury-a systematic literature search of studies using the EQ-5D.
Derrett S; Black J; Herbison GP
J Trauma; 2009 Oct; 67(4):883-90. PubMed ID: 19820601
[TBL] [Abstract][Full Text] [Related]
40. Is EQ-5D a valid quality of life instrument in patients with acute coronary syndrome?
Kahyaoğlu Süt H; Unsar S
Anadolu Kardiyol Derg; 2011 Mar; 11(2):156-62. PubMed ID: 21342862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
